RPL is the minimal structural part of CPQPRPLC, a peptide obtained via phage display-library screening [261] that binds both VEGFR-1 (vascular endothelial growth factor) and NRP-1 (neuropilin-1), two essential contributors to angiogenesis whose inhibition can lead to a decrease in tumor size. This evidence concerns the gene NRP1 and neoplasm.